PERT yields 500000.00% · JNJ yields 2.14%● Live data
📍 PERT pulled ahead of the other in Year 1
Combined, PERT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PERT + JNJ for your $10,000?
Permanent Technologies, Inc. manufactures, designs, and engineers vibration proof fastening systems in the United States and internationally. It primarily offers the TineLok product, a patented, one-way nut and bolt combination, which locks the nut and bolt at predefined positions, eliminating the possibility that vibration may loosen the nut or bolt. The company's fastener assemblies include hex, socket, square, metric hex, metric socket, and metric square head bolts and nuts. Its products are used in various applications, such as automotive, plumbing/valve assemblies, aerospace, marine/military, research and private, defense, agriculture, structural, railways, electronic and medical, as well as highway, bridge, and tunnel applications. Permanent Technologies, Inc. was incorporated in 1994 and is headquartered in Quincy, Massachusetts.
Full PERT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.